SYNTHON B.V. – Trademark Portfolio
Entity Type: 16
SYNTHON B.V. has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 100% registration rate. The portfolio includes marks such as SYNTHON and GRIPMATE. Filings span 6 Nice Classification classes, with the highest activity in Class 35 (Advertising & Business) and Class 42 (Computer & Scientific). This trademark owner is based in CM NIJMEGEN.
MICROWEG 22
CM NIJMEGEN 6545 , NL
Showing of trademarks Trademarks
Trademark Classifications
SYNTHON B.V.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SYNTHON B.V. have?
SYNTHON B.V. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does SYNTHON B.V. file in?
SYNTHON B.V. files trademarks across 6 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are SYNTHON B.V.'s most well-known trademarks?
SYNTHON B.V.'s registered trademark portfolio includes well-known marks such as SYNTHON and GRIPMATE. These are among 3 currently registered trademarks in the portfolio.
What is SYNTHON B.V.'s trademark registration success rate?
SYNTHON B.V. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.